ANGELIS Oncology launches, acquires PLX038, and initiates clinical trial in glioblastoma.
SAN FRANCISCO, CA, UNITED STATES, September 14, 2026 /EINPresswire.com/ -- ANGELIS Oncology, Inc. today announced its launch and the acquisition of PLX038 from ProLynx, Inc. The new company, founded by Daniel Santi, M.D., Ph.D., will initially focus on …